Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guanidine in type B botulism.

S J Oh, J H Halsey, D D Briggs

    Archives of Internal Medicine
    |May 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Guanidine improved botulism type B symptoms and electrophysiology in one patient. It did not help autonomic dysfunction but had no severe side effects, showing potential as an add-on therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Amifampridine to treat Lambert-Eaton myasthenic syndrome.

    Drugs of today (Barcelona, Spain : 1998)·2020
    Same author

    Effects of particulate matter on healthy human skin: a panel study using a smartphone application measuring daily skin condition.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease.

    Lupus·2017
    Same author

    API5 confers cancer stem cell-like properties through the FGF2-NANOG axis.

    Oncogenesis·2017
    Same author

    Engineering the surface chemistry of lead chalcogenide nanocrystal solids to enhance carrier mobility and lifetime in optoelectronic devices.

    Chemical communications (Cambridge, England)·2016
    Same author

    Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Area of Science:

    • Neurology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Botulism, type B, is a rare but serious neuroparalytic illness caused by Clostridium botulinum toxin.
    • Current treatment primarily involves antitoxin therapy and supportive care, with limited options for managing persistent neuromuscular symptoms.
    • Autonomic dysfunction can complicate botulism, affecting cardiovascular and gastrointestinal functions.

    Observation:

    • A 54-year-old male patient with botulism type B experienced clinical and electrophysiological improvements on two separate occasions after guanidine administration.
    • The patient's autonomic dysfunction, however, did not respond to guanidine treatment.
    • No intolerable side effects were reported during the treatment period.

    Findings:

    • Guanidine demonstrated efficacy in ameliorating both clinical and electrophysiological manifestations of botulism type B in this patient.

    Related Experiment Videos

  • Guanidine's effectiveness was limited to neuromuscular symptoms, showing no benefit for autonomic dysfunction.
  • The safety profile of guanidine appeared favorable, with no significant adverse events observed.

    • Implications:

    • Guanidine may serve as a valuable adjunctive therapy for managing neuromuscular deficits in botulism type B.
    • Further research is warranted to explore guanidine's role in botulism treatment and its specific effects on different symptom clusters.
    • This case highlights the potential utility of repurposed drugs in managing rare neuroinfectious diseases.